Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Orphan Nuclear Receptors | 4 | 2023 | 10 | 2.210 |
Why?
|
| Breast Neoplasms | 6 | 2023 | 107 | 2.090 |
Why?
|
| Antineoplastic Agents | 3 | 2015 | 72 | 1.270 |
Why?
|
| Liver X Receptors | 5 | 2023 | 18 | 1.250 |
Why?
|
| Ethanol | 2 | 2020 | 45 | 1.120 |
Why?
|
| Pancreatic Neoplasms | 4 | 2020 | 16 | 1.090 |
Why?
|
| Transcription Factors | 2 | 2020 | 69 | 1.070 |
Why?
|
| Signal Transduction | 7 | 2020 | 225 | 1.030 |
Why?
|
| Glutamine | 2 | 2023 | 4 | 0.900 |
Why?
|
| Cell Proliferation | 8 | 2021 | 120 | 0.860 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2020 | 3 | 0.860 |
Why?
|
| Neoplasms | 2 | 2015 | 99 | 0.840 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2020 | 55 | 0.790 |
Why?
|
| Gene Expression | 3 | 2021 | 52 | 0.750 |
Why?
|
| Estrogen Receptor alpha | 3 | 2020 | 22 | 0.720 |
Why?
|
| Calcium Signaling | 1 | 2020 | 4 | 0.700 |
Why?
|
| Carcinoma | 1 | 2020 | 3 | 0.700 |
Why?
|
| Oxidative Stress | 1 | 2020 | 59 | 0.660 |
Why?
|
| Estrogens | 2 | 2016 | 21 | 0.640 |
Why?
|
| Cell Line, Tumor | 7 | 2021 | 175 | 0.630 |
Why?
|
| Tamoxifen | 2 | 2017 | 12 | 0.630 |
Why?
|
| Benzoates | 2 | 2020 | 6 | 0.630 |
Why?
|
| Benzylamines | 2 | 2020 | 8 | 0.630 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2017 | 14 | 0.620 |
Why?
|
| Humans | 17 | 2023 | 5476 | 0.620 |
Why?
|
| Estradiol | 3 | 2020 | 16 | 0.600 |
Why?
|
| Ligands | 4 | 2023 | 55 | 0.600 |
Why?
|
| Female | 14 | 2023 | 2811 | 0.600 |
Why?
|
| Molecular Targeted Therapy | 2 | 2015 | 36 | 0.570 |
Why?
|
| Neoplasm Proteins | 2 | 2015 | 18 | 0.570 |
Why?
|
| Primates | 1 | 2016 | 8 | 0.530 |
Why?
|
| RNA, Long Noncoding | 1 | 2016 | 14 | 0.520 |
Why?
|
| Animals | 11 | 2020 | 1817 | 0.490 |
Why?
|
| MCF-7 Cells | 4 | 2020 | 17 | 0.460 |
Why?
|
| Sexual Maturation | 1 | 2014 | 4 | 0.440 |
Why?
|
| Mammary Glands, Animal | 1 | 2014 | 5 | 0.440 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 41 | 0.430 |
Why?
|
| Receptors, Estrogen | 3 | 2019 | 14 | 0.400 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2021 | 16 | 0.340 |
Why?
|
| Mice | 6 | 2020 | 719 | 0.220 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 2 | 2014 | 2 | 0.220 |
Why?
|
| Drug Inverse Agonism | 1 | 2023 | 2 | 0.200 |
Why?
|
| Oxidation-Reduction | 1 | 2023 | 24 | 0.200 |
Why?
|
| Homeostasis | 1 | 2023 | 30 | 0.200 |
Why?
|
| Human papillomavirus 16 | 1 | 2021 | 2 | 0.180 |
Why?
|
| Thyroid Hormones | 1 | 2021 | 3 | 0.180 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2021 | 4 | 0.180 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2021 | 5 | 0.180 |
Why?
|
| Carrier Proteins | 1 | 2021 | 25 | 0.170 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2020 | 7 | 0.170 |
Why?
|
| NFATC Transcription Factors | 1 | 2020 | 12 | 0.170 |
Why?
|
| Receptors, Progesterone | 1 | 2020 | 12 | 0.170 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 35 | 0.170 |
Why?
|
| Transcriptome | 1 | 2020 | 47 | 0.170 |
Why?
|
| Cell Survival | 2 | 2019 | 57 | 0.170 |
Why?
|
| Membrane Proteins | 1 | 2021 | 49 | 0.170 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 242 | 0.170 |
Why?
|
| Receptors, Androgen | 1 | 2020 | 14 | 0.170 |
Why?
|
| Estrogen Receptor beta | 1 | 2020 | 24 | 0.160 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 21 | 0.160 |
Why?
|
| Cytokines | 2 | 2017 | 37 | 0.160 |
Why?
|
| Genistein | 1 | 2019 | 5 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 26 | 0.160 |
Why?
|
| Deoxycytidine | 2 | 2019 | 5 | 0.150 |
Why?
|
| Tumor Microenvironment | 2 | 2017 | 28 | 0.150 |
Why?
|
| Apoptosis | 2 | 2019 | 55 | 0.140 |
Why?
|
| Uterus | 2 | 2014 | 11 | 0.140 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2017 | 2 | 0.140 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2017 | 4 | 0.140 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 10 | 0.130 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 55 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 23 | 0.130 |
Why?
|
| Cloning, Molecular | 1 | 2016 | 9 | 0.130 |
Why?
|
| Neuroendocrine Tumors | 1 | 2016 | 1 | 0.130 |
Why?
|
| Hydroxycholesterols | 1 | 2016 | 2 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 32 | 0.130 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 12 | 0.130 |
Why?
|
| Mammary Glands, Human | 2 | 2014 | 3 | 0.130 |
Why?
|
| Trefoil Factor-1 | 1 | 2015 | 1 | 0.120 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2015 | 3 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2015 | 6 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2015 | 5 | 0.120 |
Why?
|
| Down-Regulation | 1 | 2015 | 16 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 11 | 0.120 |
Why?
|
| Up-Regulation | 1 | 2015 | 30 | 0.120 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 35 | 0.120 |
Why?
|
| Drug Design | 1 | 2015 | 16 | 0.120 |
Why?
|
| Microarray Analysis | 1 | 2014 | 8 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2014 | 11 | 0.110 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 10 | 0.110 |
Why?
|
| Embryonic Development | 1 | 2014 | 14 | 0.110 |
Why?
|
| Mice, Inbred C3H | 1 | 2014 | 1 | 0.110 |
Why?
|
| Genotype | 1 | 2014 | 58 | 0.110 |
Why?
|
| Epithelial Cells | 1 | 2014 | 31 | 0.110 |
Why?
|
| GATA3 Transcription Factor | 1 | 2013 | 1 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2013 | 2 | 0.110 |
Why?
|
| Transcription Factor AP-2 | 1 | 2013 | 3 | 0.110 |
Why?
|
| Male | 3 | 2020 | 2765 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 35 | 0.090 |
Why?
|
| Cell Differentiation | 1 | 2012 | 75 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2012 | 55 | 0.090 |
Why?
|
| Aged | 1 | 2014 | 859 | 0.080 |
Why?
|
| Middle Aged | 1 | 2014 | 1098 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2021 | 50 | 0.080 |
Why?
|
| GTPase-Activating Proteins | 2 | 2020 | 3 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 50 | 0.080 |
Why?
|
| Adult | 1 | 2014 | 1683 | 0.070 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2020 | 1 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2020 | 1 | 0.040 |
Why?
|
| Benzopyrans | 1 | 2020 | 11 | 0.040 |
Why?
|
| Mucin-1 | 1 | 2019 | 1 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2019 | 4 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 34 | 0.040 |
Why?
|
| Models, Biological | 1 | 2019 | 131 | 0.040 |
Why?
|
| I-kappa B Kinase | 1 | 2017 | 1 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 6 | 0.030 |
Why?
|
| Transfection | 1 | 2017 | 15 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 18 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 18 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2017 | 18 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 14 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 23 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2017 | 46 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 44 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 53 | 0.030 |
Why?
|
| Cholesterol 24-Hydroxylase | 1 | 2016 | 1 | 0.030 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2016 | 1 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2017 | 33 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 3 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 9 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2016 | 17 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 7 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 30 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2016 | 16 | 0.030 |
Why?
|
| Disease Progression | 1 | 2016 | 74 | 0.030 |
Why?
|
| Vagina | 1 | 2014 | 14 | 0.030 |
Why?
|
| Hormones | 1 | 2014 | 5 | 0.030 |
Why?
|
| Fishes | 1 | 2014 | 7 | 0.030 |
Why?
|
| Birds | 1 | 2014 | 5 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2014 | 143 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 20 | 0.020 |
Why?
|
| Cell Line | 1 | 2012 | 86 | 0.020 |
Why?
|
| Child | 1 | 2014 | 657 | 0.020 |
Why?
|